IgG4-positive Cell Quantification Distinguishes Between Inflammatory and Noninflammatory Diseases of the Orbit.


Journal

Applied immunohistochemistry & molecular morphology : AIMM
ISSN: 1533-4058
Titre abrégé: Appl Immunohistochem Mol Morphol
Pays: United States
ID NLM: 100888796

Informations de publication

Date de publication:
07 2020
Historique:
pubmed: 6 4 2019
medline: 20 7 2021
entrez: 6 4 2019
Statut: ppublish

Résumé

IgG4-related ophthalmic disease (IgG4-ROD) is a rare inflammatory disorder often refractory to corticosteroids and prone to recurrence. IgG4-ROD may frequently lack the characteristic histopathological features seen in other organs. Thus, the criteria for diagnosis of IgG4-ROD relies on elevated IgG4 cells seen on biopsied tissue. Proposed threshold levels of IgG4 to diagnose IgG4-ROD are currently based on a limited understanding of this cell type's presence in the orbit. This study seeks to describe the population of IgG4 in inflammatory and noninflammatory orbital tissues. A tertiary care center's pathology database was searched with keywords "orbit" or "orbital" from 1995 to 2013. Specimens meeting the selection criteria were evaluated, and regions of highest inflammation were identified and immunostained with IgG4 and CD138 antibodies. Immunohistochemical quantification proceeded as previously established by the international consensus criteria. Eighteen cases without a history of orbital inflammation were included as controls and were evaluated as above. Specimens from 68 inflammatory and 18 noninflammatory orbits met the selection criteria. Pathologist interreader correlation coefficient on quantification was >0.70 (P<0.001). The mean IgG4+/high powered field (HPF) and IgG4+/CD138 was 10.3 and 0.1 in inflammatory tissues and 0.5 and 0.01 in noninflammatory tissues, respectively. The spearman rho correlation coefficient between IgG4/HPF and IgG4+/CD138+ was >0.95 (P<0.0001). The mean IgG4/HPF in our study reached previously proposed threshold values for diagnosis of IgG4-ROD, illustrating the need for further discussion regarding diagnostic criteria of IgG4-ROD.

Identifiants

pubmed: 30950839
doi: 10.1097/PAI.0000000000000767
pii: 00129039-202007000-00006
doi:

Substances chimiques

Immunoglobulin G 0
SDC1 protein, human 0
Syndecan-1 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

448-452

Références

Wallace ZS, Deshpande V, Stone JH. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review. Semin Arthritis Rheum. 2014;43:806–817.
Andrew NH, Sladden N, Kearney DJ, et al. An analysis of IgG4-related disease (IgG4-RD) among idiopathic orbital inflammations and benign lymphoid hyperplasias using two consensus-based diagnostic criteria for IgG4-RD. Br J Ophthalmol. 2015;99:376–381.
Sato Y, Ohshima K, Ichimura K, et al. Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol Int. 2008;58:465–470.
McNab AA, McKelvie P. IgG4-related ophthalmic disease. part i: background and pathology. Ophthal Plast Reconstr Surg. 2015;31:83–88.
Carruthers MN, Khosroshahi A, Augustin T, et al. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015;74:14–18.
Mulay K, Wick MR. Ophthalmic immunoglobulin G4-related disease IgG4-RD Current concepts. Semin Diagn Pathol. 2016;33:148–155.
Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181–1192.
McNab AA, McKelvie P. IgG4-related ophthalmic disease. Part II: clinical aspects. Ophthal Plast Reconstr Surg. 2015;31:167–178.
Andrew N, Kearney D, Selva D. Applying the consensus statement on the pathology of IgG4-related disease to lacrimal gland lesions. Mod Pathol. 2013;26:1150–1151.
Deschamps R, Deschamps L, Depaz R, et al. High prevalence of IgG4-related lymphoplasmacytic infiltrative disorder in 25 patients with orbital inflammation: a retrospective case series. Br J Ophthalmol. 2013;97:999–1004.
Cimino PJ, Kung Y, Warrick JI, et al. Mutational status of IDH1 in uveal melanoma. Exp Mol Pathol. 2016;100:476–481.
Wu A, Andrew NH, McNab AA, et al. IgG4-related ophthalmic disease: pooling of published cases and literature review. Curr Allergy Asthma Rep. 2015;15:27.
Wong AJ, Planck SR, Choi D, et al. IgG4 immunostaining and its implications in orbital inflammatory disease. PLoS One. 2014;9:e109847.
Chang SY, Keogh KA, Lewis JE, et al. IgG4-positive plasma cells in granulomatosis with polyangiitis (Wegener’s): a clinicopathologic and immunohistochemical study on 43 granulomatosis with polyangiitis and 20 control cases. Hum Pathol. 2013;44:2432–2437.
Plaza JA, Garrity JA, Dogan A, et al. Orbital inflammation with IgG4-positive plasma cells: manifestation of IgG4 systemic disease. Arch Ophthalmol. 2011;129:421–428.
Goto H, Takahira M, Azumi A. Disease JSGfI-RO. Diagnostic Criteria for IgG4-related Ophthalmic Disease. Nippon Ganka Gakkai Zasshi. 2016;120:365–368.
Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21–30.
Wu X, Luo QL, Li GD. A clinicopathological study of IgG4-related ocular disease and differentiated diagnosis with non-IgG4-related ocular disorders. Zhonghua Yan Ke Za Zhi. 2016;52:256–262.

Auteurs

Adam R Sweeney (AR)

Departments of Ophthalmology.

Christopher D Keene (CD)

Pathology, University of Washington, Seattle, WA.

Patrick J Cimino (PJ)

Pathology, University of Washington, Seattle, WA.

Shu-Hong Chang (SH)

Departments of Ophthalmology.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH